Literature DB >> 23004677

Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation.

Sung Hwan Ki1, Jung-Woon Lee, Sung Chul Lim, Tran Thi Hien, Ji Hye Im, Won Keun Oh, Moo Yeol Lee, Young Hyun Ji, Yoon Gyoon Kim, Keon Wook Kang.   

Abstract

BACKGROUND AND
PURPOSE: Neointima is considered a critical event in the development of vascular occlusive disease. Nectandrin B from nutmeg functions as a potent AMP-activated protein kinase (AMPK) activators. The present study addressed whether nectandrin B inhibits intimal hyperplasia in guide wire-injured arteries and examined its molecular mechanism. EXPERIMENTAL APPROACH: Neointima was induced by guide wire injury in mouse femoral arteries. Cell proliferation and mechanism studies were performed in rat vascular smooth muscle cells (VSMC) culture model. KEY
RESULTS: Nectandrin B increased AMPK activity in VSMC. Nectandrin B inhibited the cell proliferation induced by PDGF and DNA synthesis. Moreover, treatment of nectandrin B suppressed neointima formation in femoral artery after guide wire injury. We have recently shown that Pin1 plays a critical role in VSMC proliferation and neointima formation. Nectandrin B potently blocked PDGF-induced Pin1 and cyclin D1 expression and nectandrin B's anti-proliferation effect was diminished in Pin1 overexpressed VSMC. PDGF-induced phosphorylation of ERK and Akt was marginally affected by nectandrin B. However, nectandrin B increased the levels of p53 and its downstream target p21 and, also reversibly decreased the expression of E2F1 and phosphorylated Rb in PDGF-treated VSMC. AMPK inhibition by dominant mutant form of adenovirus rescued nectandrin B-mediated down-regulation of Pin1 and E2F1. CONCLUSIONS AND IMPLICATIONS: Nectandrin B inhibited VSMC proliferation and neointima formation via inhibition of E2F1-dependent Pin1 gene transcription, which is mediated through the activation of an AMPK/p53-triggered pathway.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23004677      PMCID: PMC3631381          DOI: 10.1111/j.1476-5381.2012.02228.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Acute and chronic smooth muscle cell apoptosis after mechanical vascular injury can occur independently of the Fas-death pathway.

Authors:  M Sata; S Sugiura; M Yoshizumi; Y Ouchi; Y Hirata; R Nagai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

Review 2.  Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis.

Authors:  J C Choy; D J Granville; D W Hunt; B M McManus
Journal:  J Mol Cell Cardiol       Date:  2001-09       Impact factor: 5.000

Review 3.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

4.  AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells.

Authors:  Ping Song; Shuangxi Wang; Chaoyong He; Shaobin Wang; Bin Liang; Benoit Viollet; Ming-Hui Zou
Journal:  Circ Res       Date:  2011-10-06       Impact factor: 17.367

5.  PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

Authors:  Kwang Youl Lee; Jeong Woon Lee; Hyun Jeong Nam; Jeong-Hyun Shim; Youngsup Song; Keon Wook Kang
Journal:  Mol Cells       Date:  2011-05-11       Impact factor: 5.034

6.  AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect.

Authors:  Phi Hung Nguyen; Thi Van Thu Le; Hu Won Kang; Jooyoung Chae; Sang Kyum Kim; Kwang-iI Kwon; Dae Bang Seo; Sang Jun Lee; Won Keun Oh
Journal:  Bioorg Med Chem Lett       Date:  2010-06-10       Impact factor: 2.823

7.  IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry.

Authors:  Han You; Hongwu Zheng; Steven A Murray; Qiang Yu; Takafumi Uchida; Daiming Fan; Zhi-Xiong Jim Xiao
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

8.  Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.

Authors:  D Goukassian; S M Sanz-González; I Pérez-Roger; J Font de Mora; J Ureña; V Andrés
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

9.  Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.

Authors:  A Ryo; M Nakamura; G Wulf; Y C Liou; K P Lu
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

10.  Role of Pin1 in neointima formation: down-regulation of Nrf2-dependent heme oxygenase-1 expression by Pin1.

Authors:  Sang Eun Kim; Moo Yeol Lee; Sung Chul Lim; Tran Thi Hien; Jung Woo Kim; Sang-Gun Ahn; Jung-Hoon Yoon; Sang Kyum Kim; Hong Seok Choi; Keon Wook Kang
Journal:  Free Radic Biol Med       Date:  2010-03-20       Impact factor: 7.376

View more
  10 in total

1.  Chemical diversity and pharmacological significance of the secondary metabolites of nutmeg (Myristica fragrans Houtt.).

Authors:  Ehab A Abourashed; Abir T El-Alfy
Journal:  Phytochem Rev       Date:  2016-05-10       Impact factor: 5.374

2.  Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies.

Authors:  Xiaoying Huang; Rong Fan; Yuanyuan Lu; Chang Yu; Xiaomei Xu; Xie Zhang; Panpan Liu; Shuangquan Yan; Chun Chen; Liangxing Wang
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

3.  Erratum.

Authors: 
Journal:  Br J Pharmacol       Date:  2017-01       Impact factor: 8.739

Review 4.  Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.

Authors:  Richard T Arkwright; Rahul Deshmukh; Nikhil Adapa; Ryan Stevens; Emily Zonder; Zhongyu Zhang; Pershang Farshi; Reda Saber Ibrahim Ahmed; Hossny Awad El-Banna; Tak-Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2015       Impact factor: 2.505

5.  Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries.

Authors:  Xiao-Lin Xiao; Nan Hu; Xin-Zi Zhang; Man Jiang; Chang Chen; Rui Ma; Zhen-Gang Ma; Jin-Lai Gao; Xiu-Chen Xuan; Zhi-Jie Sun; De-Li Dong
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

6.  Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis.

Authors:  Hang-Che Yang; Jian-Ying Chuang; Wen-Yih Jeng; Chia-I Liu; Andrew H-J Wang; Pei-Jung Lu; Wen-Chang Chang; Jan-Jong Hung
Journal:  Nucleic Acids Res       Date:  2014-11-14       Impact factor: 16.971

Review 7.  Regulation of AMP-activated protein kinase by natural and synthetic activators.

Authors:  David Grahame Hardie
Journal:  Acta Pharm Sin B       Date:  2015-07-21       Impact factor: 11.413

8.  Nectandrin B-mediated activation of the AMPK pathway prevents cellular senescence in human diploid fibroblasts by reducing intracellular ROS levels.

Authors:  Hyun-Jin Jang; Kyeong Eun Yang; Won Keun Oh; Song-I Lee; In-Hu Hwang; Kyung-Tae Ban; Hwa-Seung Yoo; Jong-Soon Choi; Eui-Ju Yeo; Ik-Soon Jang
Journal:  Aging (Albany NY)       Date:  2019-06-14       Impact factor: 5.682

Review 9.  Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.

Authors:  Jingyi Li; Chunfen Mo; Yifan Guo; Bowen Zhang; Xiao Feng; Qiuyue Si; Xiaobo Wu; Zhe Zhao; Lixin Gong; Dan He; Jichun Shao
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

10.  Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase.

Authors:  Wen-yu Wu; Hong Yan; Xin-bo Wang; Yu-zhou Gui; Fei Gao; Xi-lan Tang; Yin-lin Qin; Mei Su; Tao Chen; Yi-ping Wang
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.